NCT05739981
Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer
IMNN — Imunon, Inc.
Phase 1, Phase 2
• Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
TL;DR
Enrollment 50→30 (-40%) — PHASE1, PHASE2
What changed
- Enrollment: 50 → 30
Recent events (last 90 days)
2026-01-12
MEDIUM
Enrollment 50→30 (-40%) — PHASE1, PHASE2
Phase 1, Phase 2 • Enrollment 50→30
What to check next
- Review CT.gov update history and company disclosures for context.
- Verify whether registry updates lag press releases.